Publications found:
1,234
Sort by:
Lung Adenocarcinoma Treatment Market Size, Share and Growth Outlook 2026: By Treatment Type (Targeted Therapy, Immunotherapy, Chemotherapy, Surgery, Radiation Therapy), By Stage of Disease, By End-User, By Distribution Channel, Companies to 2034.
US$ 3,482.00
The global Lung Adenocarcinoma Treatment Market size is forecast to increase from $7.85 Billion in 2026 to $17.66 Billion in 2034 at a CAGR of 10.67% between 2026 and 2034. The Lung Adenocarcinoma Tre...
July 2026
190 pages
Soft Contact Lens Market Size, Share and Growth Outlook 2026: By Material (Silicone Hydrogel, Hydrogel, PMMA, Others), By Design, By Usability, By Application, By Distribution Channel, Companies to 2034.
US$ 3,482.00
The global Soft Contact Lens Market size is forecast to increase from $11.39 Billion in 2026 to $21.46 Billion in 2034 at a CAGR of 8.24% between 2026 and 2034. The Soft Contact Lens market report pro...
July 2026
190 pages
Global Sarcosine Market Growth 2026-2032
US$ 3,660.00
The global Sarcosine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Sarcosine, also known as N-methylglycine,...
July 2026
91 pages
Global Bone Cancer Treatment Market Size Study and Forecast by Drug Class (Cytotoxic Chemotherapy Agents, Tyrosine Kinase Inhibitors (TKIs), Immune Checkpoint Inhibitors, RANKL Inhibitors, IDH Inhibitors, Bisphosphonates, by Cancer Type, by Age Group (Pediatric, Adults), by Therapy, by Route of Administration, by Distribution Channel, and Regional Forecasts 2026–2036
US$ 3,750.00
The Global Bone Cancer Treatment Market, valued at USD 1.32 billion in 2025, is projected to reach USD 2.31 billion by 2036, registering a CAGR of 5.2% during 2026–2036. Bone cancer treatment involves...
July 2026
285 pages
Immuno Oncology Assays Market - 2025-2033
US$ 3,400.00
Immuno Oncology Assays Marketis is growing with a CAGR of 12.80% during the forecast period 2026-2035. The Immuno Oncology Assays Market emerges as a key focus in DataM Intelligence latest in-depth an...
July 2026
48 pages
Global Cancer of Unknown Primary (CUP) Therapeutics Market Size Study and Forecast by Drug Class (Platinum Compounds, Taxanes, Immune Checkpoint Inhibitors, Antimetabolites, HER2-Directed ADCs, TRK Inhibitors, BRAF) by Therapy Type, by Age Group, by Route of Administration, by Distribution Channel, and Regional Forecasts 2026–2036
US$ 3,750.00
The Global Cancer of Unknown Primary (CUP) Therapeutics Market, valued at USD 2.25 billion in 2025, is projected to reach USD 4.50 billion by 2036, registering a CAGR of 6.5% during 2026–2036.Cancer o...
July 2026
285 pages
Blood Cancer Therapeutics: Global Markets to 2030
US$ 4,650.00
... , reimbursement and patents. It analyzes prevailing blood cancer treatment guidelines in different geographic regions. The scope of the blood cancer therapeutic market is restricted to three disease areas: leukemia ...
July 2026
214 pages
Radioligand Therapy Market - 2026-2035
US$ 3,400.00
Radioligand Therapy Market reached US$ 2.94 billion in 2025 and is expected to reach US$ 21.30 billion by 2035, growing with a CAGR of 21.90% during the forecast period 2026-2035. The Radioligand Ther...
July 2026
45 pages
South Korea Cancer Immunotherapy Market Report by Therapy Type (Monoclonal Antibodies, Cancer Vaccines, Checkpoint Inhibitors, Immunomodulators, and Others), Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, and Others), End User (Hospitals, Cancer Research Centers, Clinics, and Others), and Region 2026-2034
US$ 2,999.00
South Korea cancer immunotherapy market size reached USD 2.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 5.4 Billion by 2034, exhibiting a growth rate (CAGR) of 7.79%...
July 2026
119 pages
